Number of shares and votes in Medivir AB on 28 June 2024

Rhea-AI Summary

Medivir AB (NASDAQ: MVIR) announced a change in the number of shares and votes due to issuing 1,700,000 series C shares and reclassifying 114,587 series C shares to ordinary shares. This change is part of an incentive program approved on May 7, 2024. As of June 28, 2024, Medivir has a total of 114,617,968 shares, comprising 112,167,805 ordinary shares and 2,450,163 series C shares, with a combined total of 112,412,821 votes. Each ordinary share entitles one vote and each series C share entitles one-tenth of a vote.

Positive

• Issuance of 1,700,000 series C shares.
• Reclassification of 114,587 series C shares to ordinary shares.

Negative

• Potential dilution for shareholders due to the increase in the total number of shares.

STOCKHOLM, June 28, 2024 /PRNewswire/ -- Medivir AB (NASDAQ: MVIR) (STOCKHOLM: MVIR) today announces that the number of shares and votes in Medivir has changed during June 2024 as a result of the issue of 1,700,000 shares of series C and the reclassification of 114 587 shares of series C to ordinary shares which was carried out as a part of the implementation of the incentive program resolved by the general meeting on 7 May 2024. Both the issue and the reclassification have been previously announced through a separate press release.

Today, the last trading day of the month, there are in total 114,617,968 shares in Medivir, of which 112,167,805 are ordinary shares and 2,450,163 are shares of series C, together carrying 112,412,821 votes. One ordinary share entitles to one (1) vote and one share of series C entitles to one tenth (1/10) of a vote. All shares of series C are held by the company.

For additional information, please contact:

Magnus Christensen, CFO, Medivir AB
Telephone: +46 8 5468 3100
E-mail: magnus.christensen@medivir.com 

This information is such information that Medivir AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was sent for publication, through the agency of the contact person set out above, at the time stated by the Company's news distributor set out above at the publication of this press release.

About Medivir

Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward indication areas where available therapies are limited or missing and there are great opportunities to offer significant improvements to patients. Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a smart, targeted chemotherapy designed to selectively treat liver cancer cells and to minimize side effects. Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership. Medivir's share (ticker: MVIR) is listed on Nasdaq Stockholm's Small Cap list. www.medivir.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/medivir/r/number-of-shares-and-votes-in-medivir-ab-on-28-june-2024,c4008524

The following files are available for download:

https://mb.cision.com/Main/652/4008524/2890918.pdf

Press release (PDF)

 

View original content:https://www.prnewswire.com/news-releases/number-of-shares-and-votes-in-medivir-ab-on-28-june-2024-302185603.html

SOURCE Medivir

FAQ

What changes occurred in the number of shares for Medivir AB (MVIR) in June 2024?

Medivir issued 1,700,000 series C shares and reclassified 114,587 series C shares to ordinary shares.

How many total shares does Medivir AB (MVIR) have as of June 28, 2024?

Medivir has a total of 114,617,968 shares.

How many ordinary shares does Medivir AB (MVIR) have as of June 28, 2024?

Medivir has 112,167,805 ordinary shares.

How many series C shares does Medivir AB (MVIR) have as of June 28, 2024?

Medivir has 2,450,163 series C shares.

What is the total number of votes for Medivir AB (MVIR) as of June 28, 2024?

Medivir has a total of 112,412,821 votes.

What is the voting entitlement for Medivir AB (MVIR) shares?

Each ordinary share entitles to one vote and each series C share entitles to one-tenth of a vote.